Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma

Shingo Soma, Koji Tsuta, Toshimi Takano, Yutaka Hatanaka, Akihiko Yoshida, Kenji Suzuki, Hisao Asamura, Hitoshi Tsuda

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Alterations in the epidermal growth factor receptor (EGFR) gene are associated with carcinogenesis in non-small cell lung cancer. However, the intratumoral distribution of these abnormalities has not been elucidated.This study included patients with surgically resected lung adenocarcinoma. The predominant histological growth pattern was determined. Chromogenic in situ hybridization (CISH) and EGFR-mutation specific-antibodies were used for analysis of changes in gene copy number and EGFR mutations, respectively.EGFR mutation detected immunohistochemistry (IHC) and amplification were identified in 31 (53%) and 30 (52%) cases, respectively. The predominant growth patterns in the 58 tumors evaluated were papillary (28, 48%), lepidic (8, 14%), acinar (15, 26%), and solid (7, 12%). EGFR mutations were the least common in cases with a solid predominant pattern. The incidence of EGFR amplification did not differ among predominant patterns. Analyzing each histological subtype, no differences were noted between the prevalence of EGFR-IHC positive and CISH-positive rates. In the analysis of EGFR amplification, CISH-positive status was more prevalent in IHC-positive cases than in IHC-negative cases. All 19 cases that were both IHC and CISH positive were analyzed. In 17 cases (90%), the IHC-positive area was equal to or larger than the CISH-positive area.Among the histological subtypes of lung adenocarcinoma, the solid predominant subtype was distinguishable by its infrequent EGFR mutations. EGFR gene mutations preceded changes in oncogenic drive, more so than did EGFR gene number alterations during the developmental process of lung adenocarcinoma.

Original languageEnglish
Pages (from-to)155-160
Number of pages6
JournalPathology Research and Practice
Volume210
Issue number3
DOIs
Publication statusPublished - 2014 Mar
Externally publishedYes

Fingerprint

Epidermal Growth Factor Receptor
Immunohistochemistry
In Situ Hybridization
erbB-1 Genes
Mutation
Gene Dosage
Adenocarcinoma of lung
Growth
Non-Small Cell Lung Carcinoma
Carcinogenesis
Antibodies
Incidence
Neoplasms

Keywords

  • Adenocarcinoma of the lung
  • Chromogenic in situ hybridization
  • Epidermal growth factor receptor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Soma, S., Tsuta, K., Takano, T., Hatanaka, Y., Yoshida, A., Suzuki, K., ... Tsuda, H. (2014). Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma. Pathology Research and Practice, 210(3), 155-160. https://doi.org/10.1016/j.prp.2013.11.008

Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma. / Soma, Shingo; Tsuta, Koji; Takano, Toshimi; Hatanaka, Yutaka; Yoshida, Akihiko; Suzuki, Kenji; Asamura, Hisao; Tsuda, Hitoshi.

In: Pathology Research and Practice, Vol. 210, No. 3, 03.2014, p. 155-160.

Research output: Contribution to journalArticle

Soma, Shingo ; Tsuta, Koji ; Takano, Toshimi ; Hatanaka, Yutaka ; Yoshida, Akihiko ; Suzuki, Kenji ; Asamura, Hisao ; Tsuda, Hitoshi. / Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma. In: Pathology Research and Practice. 2014 ; Vol. 210, No. 3. pp. 155-160.
@article{7c18c377a1884fe098947a70af3f874a,
title = "Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma",
abstract = "Alterations in the epidermal growth factor receptor (EGFR) gene are associated with carcinogenesis in non-small cell lung cancer. However, the intratumoral distribution of these abnormalities has not been elucidated.This study included patients with surgically resected lung adenocarcinoma. The predominant histological growth pattern was determined. Chromogenic in situ hybridization (CISH) and EGFR-mutation specific-antibodies were used for analysis of changes in gene copy number and EGFR mutations, respectively.EGFR mutation detected immunohistochemistry (IHC) and amplification were identified in 31 (53{\%}) and 30 (52{\%}) cases, respectively. The predominant growth patterns in the 58 tumors evaluated were papillary (28, 48{\%}), lepidic (8, 14{\%}), acinar (15, 26{\%}), and solid (7, 12{\%}). EGFR mutations were the least common in cases with a solid predominant pattern. The incidence of EGFR amplification did not differ among predominant patterns. Analyzing each histological subtype, no differences were noted between the prevalence of EGFR-IHC positive and CISH-positive rates. In the analysis of EGFR amplification, CISH-positive status was more prevalent in IHC-positive cases than in IHC-negative cases. All 19 cases that were both IHC and CISH positive were analyzed. In 17 cases (90{\%}), the IHC-positive area was equal to or larger than the CISH-positive area.Among the histological subtypes of lung adenocarcinoma, the solid predominant subtype was distinguishable by its infrequent EGFR mutations. EGFR gene mutations preceded changes in oncogenic drive, more so than did EGFR gene number alterations during the developmental process of lung adenocarcinoma.",
keywords = "Adenocarcinoma of the lung, Chromogenic in situ hybridization, Epidermal growth factor receptor",
author = "Shingo Soma and Koji Tsuta and Toshimi Takano and Yutaka Hatanaka and Akihiko Yoshida and Kenji Suzuki and Hisao Asamura and Hitoshi Tsuda",
year = "2014",
month = "3",
doi = "10.1016/j.prp.2013.11.008",
language = "English",
volume = "210",
pages = "155--160",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "3",

}

TY - JOUR

T1 - Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma

AU - Soma, Shingo

AU - Tsuta, Koji

AU - Takano, Toshimi

AU - Hatanaka, Yutaka

AU - Yoshida, Akihiko

AU - Suzuki, Kenji

AU - Asamura, Hisao

AU - Tsuda, Hitoshi

PY - 2014/3

Y1 - 2014/3

N2 - Alterations in the epidermal growth factor receptor (EGFR) gene are associated with carcinogenesis in non-small cell lung cancer. However, the intratumoral distribution of these abnormalities has not been elucidated.This study included patients with surgically resected lung adenocarcinoma. The predominant histological growth pattern was determined. Chromogenic in situ hybridization (CISH) and EGFR-mutation specific-antibodies were used for analysis of changes in gene copy number and EGFR mutations, respectively.EGFR mutation detected immunohistochemistry (IHC) and amplification were identified in 31 (53%) and 30 (52%) cases, respectively. The predominant growth patterns in the 58 tumors evaluated were papillary (28, 48%), lepidic (8, 14%), acinar (15, 26%), and solid (7, 12%). EGFR mutations were the least common in cases with a solid predominant pattern. The incidence of EGFR amplification did not differ among predominant patterns. Analyzing each histological subtype, no differences were noted between the prevalence of EGFR-IHC positive and CISH-positive rates. In the analysis of EGFR amplification, CISH-positive status was more prevalent in IHC-positive cases than in IHC-negative cases. All 19 cases that were both IHC and CISH positive were analyzed. In 17 cases (90%), the IHC-positive area was equal to or larger than the CISH-positive area.Among the histological subtypes of lung adenocarcinoma, the solid predominant subtype was distinguishable by its infrequent EGFR mutations. EGFR gene mutations preceded changes in oncogenic drive, more so than did EGFR gene number alterations during the developmental process of lung adenocarcinoma.

AB - Alterations in the epidermal growth factor receptor (EGFR) gene are associated with carcinogenesis in non-small cell lung cancer. However, the intratumoral distribution of these abnormalities has not been elucidated.This study included patients with surgically resected lung adenocarcinoma. The predominant histological growth pattern was determined. Chromogenic in situ hybridization (CISH) and EGFR-mutation specific-antibodies were used for analysis of changes in gene copy number and EGFR mutations, respectively.EGFR mutation detected immunohistochemistry (IHC) and amplification were identified in 31 (53%) and 30 (52%) cases, respectively. The predominant growth patterns in the 58 tumors evaluated were papillary (28, 48%), lepidic (8, 14%), acinar (15, 26%), and solid (7, 12%). EGFR mutations were the least common in cases with a solid predominant pattern. The incidence of EGFR amplification did not differ among predominant patterns. Analyzing each histological subtype, no differences were noted between the prevalence of EGFR-IHC positive and CISH-positive rates. In the analysis of EGFR amplification, CISH-positive status was more prevalent in IHC-positive cases than in IHC-negative cases. All 19 cases that were both IHC and CISH positive were analyzed. In 17 cases (90%), the IHC-positive area was equal to or larger than the CISH-positive area.Among the histological subtypes of lung adenocarcinoma, the solid predominant subtype was distinguishable by its infrequent EGFR mutations. EGFR gene mutations preceded changes in oncogenic drive, more so than did EGFR gene number alterations during the developmental process of lung adenocarcinoma.

KW - Adenocarcinoma of the lung

KW - Chromogenic in situ hybridization

KW - Epidermal growth factor receptor

UR - http://www.scopus.com/inward/record.url?scp=84893793063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893793063&partnerID=8YFLogxK

U2 - 10.1016/j.prp.2013.11.008

DO - 10.1016/j.prp.2013.11.008

M3 - Article

C2 - 24355440

AN - SCOPUS:84893793063

VL - 210

SP - 155

EP - 160

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 3

ER -